Parent Outlook: How Parents View the Road Ahead as They Embark on Hematopoietic Stem Cell Transplantation for Their

Christina K Ullrich1, Angie Mae Rodday2, Kristin Bingen3

  • 1Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medicine, Boston Children's Hospital, Boston, Massachusetts.

Insights

Parental outlook on pediatric hematopoietic stem cell transplantation (HSCT) varies widely. This study introduces the Parent Outlook Scale, finding that parents worry more about transplant difficulty than future health, influenced by clinical and emotional factors.

Area of Science:

  • Pediatric Hematology/Oncology
  • Psychosocial Oncology
  • Clinical Psychology

Background:

  • Pediatric hematopoietic stem cell transplantation (HSCT) is a curative option for high-risk conditions but involves significant parental stress.
  • Parental perspectives on their child's HSCT journey and long-term health outcomes remain under-researched.
  • Understanding parental outlook is crucial for providing comprehensive psychosocial support during HSCT.

Purpose of the Study:

  • To introduce and validate the Parent Outlook Scale (POS) for assessing parental concerns during pediatric HSCT.
  • To examine the outlook of parents whose children are undergoing HSCT.
  • To identify personal and clinical factors associated with parental outlook.

Main Methods:

  • Developed and administered the Parent Outlook Scale to 363 parents of children scheduled for HSCT across 8 US centers.
  • The POS includes 4 items assessing thoughts on transplant difficulty and worsened health, using a 5-point Likert scale.
  • Explored psychometric properties and used multivariable models to identify associated variables.

Main Results:

  • The Parent Outlook Scale demonstrated sound psychometric properties (Cronbach's alpha = 0.75).
  • Parents reported more frequent thoughts about transplant difficulty (64.4 ± 25.6) than worsened health (40.7 ± 25.7).
  • Clinical factors (solid tumor, unrelated donor) and parental emotional functioning were linked to higher outlook scores.

Conclusions:

  • Parental outlook during pediatric HSCT is diverse and influenced by factors beyond readily apparent clinical indicators.
  • The Parent Outlook Scale is a reliable tool for quantifying parental concerns in this population.
  • Clinicians should proactively address parental perspectives and concerns before and throughout the HSCT process.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.5K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.4K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.6K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
11.6K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.1K